PATIENTS ON OHA AND INSULIN – Add FENFURO™ to the existing medicinal regimen. Recommended dosage of FENFURO™ for better and fast results is one capsule three times a day (before meal). Patient should monitor FBS & PPBS level from 7th-9th day onwards. If hypoglycemic symptoms are noticed, insulin intake can be tapered depending upon level of FBS & PPBS in consultation with your physician.
FENFURO™ dosage of three capsules is to be continued till the time insulin is no longer required. After this two capsules of FENFURO™ (one in the morning and one in the evening before meal) have to be taken with other OHA till HbA1c <7%. Once HbA1c <7% is achieved, dosage of OHA to be adjusted in consultation with your physician.
PATIENTS TAKING MULTI MOLECULE OHA – Add FENFURO™ to existing medicinal regimen. Recommended dosage of FENFURO™ for better and fast results is one capsule twice a day (one in the morning and one in the evening before meal) till HbA1c <7%. Once HbA1c <7% is achieved, dosage of OHA is to be adjusted in consultation with your physician.
If C-peptide is very low, FENFURO™ can be added to the existing medicinal regimen for three months regularly. Recommended dosage of FENFURO™ is three times a day (with meal). Patient should monitor FBS & PPBS level from 7th-9th day onwards. If hypoglycemic symptoms are noticed insulin intake can be tapered depending upon level of FBS & PPBS in consultation with your physician. After three months if any improvement is noticed in C-peptide level, patient can continue taking FENFURO™ otherwise FENFURO™ can be withdrawn.
If C-peptide is normal, probably it is MODY (Maturity-onset diabetes of the young) case & FENFURO™ can help to regenerate newer insulin receptor sites & thereby insulin dosage can be reduced and diabetic complication can be controlled by reducing hyperinsulinemia. Recommended dosage of FENFURO™ is three times a day (with meal). Patient should monitor FBS & PPBS level from 7th-9th day onwards. If hypoglycemic symptoms are noticed insulin intake can be tapered depending upon level of FBS & PPBS in consultation with your physician.
Information on this website has been posted in public interest for creating awareness about diabetes/obesity/general health. In event of any copyright conflicts, please inform so that we may take appropriate remedial measures. The products and the claims made on this site have not been evaluated by FDA and are not approved to diagnose, treat, cure or prevent diseases.
Copyright @ 2021 – All rights reserved Chemical Resources.
